Intercell increased vaccine sales in Q1

Intercell had an active 2012 first quarter, increasing sales of its vaccine against Japanese encephalitis, while starting clinical studies in candidate vaccines for tuberculosis, Pseudomonas aeruginosa and Clostridium difficile.

Location